HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 179 filers reported holding HERON THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $18,243 | -34.2% | 17,712 | -25.9% | 0.00% | – |
Q2 2023 | $27,736 | -28.1% | 23,910 | -6.4% | 0.00% | – |
Q1 2023 | $38,584 | -56.6% | 25,552 | +20.5% | 0.00% | -100.0% |
Q3 2022 | $89,000 | +4350.0% | 21,198 | +3638.6% | 0.00% | – |
Q2 2022 | $2,000 | -66.7% | 567 | -47.7% | 0.00% | – |
Q1 2022 | $6,000 | +20.0% | 1,085 | +108.3% | 0.00% | – |
Q4 2021 | $5,000 | -50.0% | 521 | -41.5% | 0.00% | – |
Q3 2021 | $10,000 | -33.3% | 891 | -10.4% | 0.00% | – |
Q2 2021 | $15,000 | +87.5% | 994 | +102.9% | 0.00% | – |
Q1 2021 | $8,000 | +300.0% | 490 | +390.0% | 0.00% | – |
Q4 2020 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q3 2020 | $2,000 | -33.3% | 100 | -50.0% | 0.00% | – |
Q2 2020 | $3,000 | -88.5% | 200 | -85.7% | 0.00% | -100.0% |
Q3 2019 | $26,000 | +550.0% | 1,396 | +598.0% | 0.00% | – |
Q2 2019 | $4,000 | -20.0% | 200 | 0.0% | 0.00% | – |
Q1 2019 | $5,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q4 2018 | $5,000 | -16.7% | 200 | 0.0% | 0.00% | – |
Q3 2018 | $6,000 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN C | 760 | $783 | 100.00% |
Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
CM Management, LLC | 450,000 | $463,500 | 0.49% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |